With regard to molecular tumor characteristics, MT1-MMP expression did neither correlate with the presence of an activating KRAS or BRAF mutation nor correlate with MMR protein expression at the leading edge of the examined tumors in our sample set (P = 0.812, 1.0, and 0.471, resp). The gene discussed is KRAS; the disease is neoplasm.